Research in the Carter-O'Connell Lab

The Carter-O'Connell lab sits at the interface of chemistry, biochemistry, molecular, cellular, and systems biology. Our lab leverages methodologies from these varied disciplines to uncover the role of ADP-ribosylation (ADPr) signaling networks within the cell. ADPr has emerged as an essential posttranslational protein modification (PTM) implicated in a wide-array of biological functions and multiple disease states, including cancer. In humans, ADP-ribose transfer is catalyzed by a series of 17 enzymes known as poly-ADP-ribose polymerases (PARPs). The PARP enzymes transfer ADP-ribose from nicotinamide adenine dinucleotide (NAD+) onto target proteins. PARP enzymes can also be divided between those that polymerize chains of poly-ADP-ribose (poly-PARPs) and those that can only add a single mono-ADP-ribose (mono-PARPs). The addition of ADP-ribose alters the charge state of the protein and can affect protein binding, activity, and stability. PARP1, a poly-PARP, has received the bulk of scientific scrutiny due to its role in single-strand base repair and the efficacy of targeting PARP1 activity in certain cancers. However, the majority of the PARPs have remained poorly understood due to a lack of tools to identify their targets in the cell.